Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA

DNA Repair

Volumn 11, Issue 3, 2012, Pages 259-266

  Lim, Teik How ^a   Fujikane, Ryosuke ^b   Sano, Shiori ^b   Sakagami, Ryuji ^b   Nakatsu, Yoshimichi ^a   Tsuzuki, Teruhisa ^a   Sekiguchi, Mutsuo ^b   Hidaka, Masumi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

AMPK; Apoptosis; Folliculin BHD; MAPO1 FNIP2 FNIPL; O 6 methylguanine

Indexed keywords

AMP ACTIVATED PROTEIN KINASE ALPHA; CELL DNA; ESTRONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; O6 METHYLGUANINE INDUCED APOPTOSIS 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BASE MISPAIRING; CELL CYCLE G1 PHASE; CELL MEMBRANE DEPOLARIZATION; CELL POPULATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

ALKYLATION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE PAIR MISMATCH; CARRIER PROTEINS; CELL LINE; DNA; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; METHYLNITROSOUREA; MICE; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 84856571332     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.11.006     Document Type: Article

References (37)

1. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 1990, 231:11-30.
2. Coulondre C., Miller J.H. Genetic studies of the lac repressor. IV. Mutagenic specificity in the lacI gene of Escherichia coli. J. Mol. Biol. 1977, 117:577-606.
3. Ito T., Nakamura T., Maki H., Sekiguchi M. Roles of transcription and repair in alkylation mutagenesis. Mutat. Res. 1994, 314:273-285.
4. Demple B., Jacobsson A., Olsson M., Robins P., Lindahl T. Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase. J. Biol. Chem. 1982, 257:13776-13780.
5. Kawate H., Ihara K., Kohda K., Sakumi K., Sekiguchi M. Mouse methyltransferase for repair of O6-methylguanine and O4-methylthymine in DNA. Carcinogenesis 1995, 16:1595-1602.
6. Branch P., Aquilina G., Bignami M., Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993, 362:652-654.
7. Hidaka M., Takagi Y., Takano T.Y., Sekiguchi M. PCNA-MutSalpha-mediated binding of MutLalpha to replicative DNA with mismatched bases to induce apoptosis in human cells. Nucleic Acids Res. 2005, 33:5703-5712.
8. Kat A., Thilly W.G., Fang W.H., Longley M.J., Li G.M., Modrich P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:6424-6428.
9. Glassner B.J., Weeda G., Allan J.M., Broekhof J.L., Carls N.H., Donker I., Engelward B.P., Hampson R.J., Hersmus R., Hickman M.J., Roth R.B., Warren H.B., Wu M.M., Hoeijmakers J.H., Samson L.D. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 1999, 14:339-347.
10. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 1997, 57:2415-2418.
11. Shiraishi A., Sakumi K., Sekiguchi M. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis 2000, 21:1879-1883.
12. Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang S., Shimizu S., Ishikawa T., et al. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis 1996, 17:1215-1220.
13. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., Takano H., Noda T., Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5116-5120.
14. Takagi Y., Takahashi M., Sanada M., Ito R., Yamaizumi M., Sekiguchi M. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis. DNA Repair (Amst.) 2003, 2:1135-1146.
15. Ochs K., Kaina B. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/Caspase-8 independent. Cancer Res. 2000, 60:5815-5824.
16. Komori K., Takagi Y., Sanada M., Lim T.H., Nakatsu Y., Tsuzuki T., Sekiguchi M., Hidaka M. A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA. Oncogene 2009, 28:1142-1150.
17. Baba M., Hong S.B., Sharma N., Warren M.B., Nickerson M.L., Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F., Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R., Linehan W.M., Schmidt L.S., Zbar B. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK and is involved in AMPK and mTOR signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15552-15557.
18. Nickerson M.L., Warren M.B., Toro J.R., Matrosova V., Glenn G., Turner M.L., Duray P., Merino M., Choyke P., Pavlovich C.P., Sharma N., Walther M., Munroe D., Hill R., Maher E., Greenberg C., Lerman M.I., Linehan W.M., Zbar B., Schmidt L.S. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2002, 2:157-164.
19. Vocke C.D., Yang Y., Pavlovich C.P., Schmidt L.S., Nickerson M.L., Torres-Cabala C.A., Merino M.J., Walther M.M., Zbar B., Linehan W.M. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J. Natl. Cancer Inst. 2005, 97:931-935.
20. Birt A.R., Hogg G.R., Dube W.J. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch. Dermatol. 1977, 113:1674-1677.
21. Toro J.R., Glenn G., Duray P., Darling T., Weirich G., Zbar B., Linehan M., Turner M.L. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch. Dermatol. 1999, 135:1195-1202.
22. Zbar B., Alvord W.G., Glenn G., Turner M., Pavlovich C.P., Schmidt L., Walther M., Choyke P., Weirich G., Hewitt S.M., Duray P., Gabril F., Greenberg C., Merino M.J., Toro J., Linehan W.M. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol. Biomarkers Prev. 2002, 11:393-400.
23. Hasumi H., Baba M., Hong S.B., Hasumi Y., Huang Y., Yao M., Valera V.A., Linehan W.M., Schmidt L.S. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 2008, 415:60-67.
24. Takagi Y., Kobayashi T., Shiono M., Wang L., Piao X., Sun G., Zhang D., Abe M., Hagiwara Y., Takahashi K., Hino O. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene 2008, 27:5339-5347.
25. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
26. Hardie D.G. The AMP-activated protein kinase pathway - new players upstream and downstream. J. Cell Sci. 2004, 117:5479-5487.
27. Hawley S.A., Davison M., Woods A., Davies S.P., Beri R.K., Carling D., Hardie D.G. Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271:27879-27887.
28. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Makela T.P., Hardie D.G., Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23:833-843.
29. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3329-3335.
30. Cao C., Lu S., Kivlin R., Wallin B., Card E., Bagdasarian A., Tamakloe T., Chu W.M., Guan K.L., Wan Y. AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J. Biol. Chem. 2008, 283:28897-28908.
31. Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., Birnbaum M.J., Thompson C.B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18:283-293.
32. Okoshi R., Ozaki T., Yamamoto H., Ando K., Koida N., Ono S., Koda T., Kamijo T., Nakagawara A., Kizaki H. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem. 2008, 283:3979-3987.
33. Zhang W.B., Wang Z., Shu F., Jin Y.H., Liu H.Y., Wang Q.J., Yang Y. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J. Biol. Chem. 2010, 285:40461-40471.
34. Hartman T.R., Nicolas E., Klein-Szanto A., Al-Saleem T., Cash T.P., Simon M.C., Henske E.P. The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene 2009, 28:1594-1604.
35. Hasumi Y., Baba M., Ajima R., Hasumi H., Valera V.A., Klein M.E., Haines D.C., Merino M.J., Hong S.B., Yamaguchi T.P., Schmidt L.S., Linehan W.M. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18722-18727.
36. Piao X., Kobayashi T., Wang L., Shiono M., Takagi Y., Sun G., Abe M., Hagiwara Y., Zhang D., Okimoto K., Kouchi M., Matsumoto I., Hino O. Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway. Biochem. Biophys. Res. Commun. 2009, 389:16-21.
37. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 2005, 37:19-24.